Early Detection of Ovarian Cancer May be Possible with Combination of Artificial Intelligence and Liquid Biopsies

A liquid biopsy - a blood test - in combination with machine learning/artificial intelligence (AI) to detect and analyze distinctive tumor components, cancer-related genetic changes, and protein biomarkers released into the peripheral circulation, could help screen women for early signs of ovarian cancer, enabling a new accessible approach for non-invasive ovarian cancer screening and diagnostic evaluation.